Yongjun Chen
Clinical trials sponsored by Yongjun Chen, explained in plain language.
-
New surgical approach could give hope to High-Risk liver cancer patients
Disease control Not yet recruitingThis study is testing whether a less extensive liver surgery approach is safer and improves survival for patients with bile duct cancer who don't have enough healthy liver tissue left for standard surgery. Researchers will follow 300 patients who either receive this modified surg…
Sponsor: Yongjun Chen • Aim: Disease control
Last updated Mar 02, 2026 15:28 UTC
-
Doctors question if aggressive surgery helps bile duct cancer patients live longer
Knowledge-focused Not yet recruitingThis study looks back at past medical records to understand if removing major blood vessels during surgery for a rare and aggressive bile duct cancer helps patients live longer or leads to more complications. Researchers will analyze data from 300 patients who had surgery with th…
Sponsor: Yongjun Chen • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC